Skip to navigation Skip to main content
Balai ni Fruitas
  • Our Company
    • What We Do
    • Who We Are
    • Organizational Chart
    • Corporate Structure
    • Shareholdings’ Structure
  • Corporate Governance
    • Corporate Governance Documents
    • Board Committees
    • Corporate Social Responsibility
    • Company’s Policies
  • Company Disclosures
  • Investor Relations
    • Investor Relations Program
    • Share Information
    • Stock Information
    • Sell-Side Coverage
    • Financial Calendar
    • Investment Highlights
    • FAQS
  • IPO Documents
Search
Browse Categories
  • Press Release
  • Latest News
  • Contact Us
Menu
Balai ni Fruitas

Monthly Archives: November 2024

Home2024November
14 Nov
Press Release

Balai ni Fruitas reports 26% revenue growth and sustained margins in 9M2024

Posted by author-avatar Balai ni Fruitas Inc.
November 22, 2024
9M2024 Highlights: 9M2024 revenue nearly reached the half-billion-mark, totaling Php487 million — a 26% increase, or Php100 million...
Continue reading

DermClinic

Balai Ni Fruitas Inc. (BNF) is a food and beverage company which houses well-known brands such as Buko Ni Fruitas, Fruitas House of Desserts, and Balai Pandesal. It is a subsidiary of Fruitas Holdings, Inc.

Headquarters: 68 Data St., Don Manuel, Quezon City Philippines

Useful Links
  • Our Company
  • Corporate Governance
  • Company Disclosures
  • IPO Documents
  • Press Release
  • News & Events
Contact Us

Call: +63 (02) 8712-8361
Email: investor.relations@balainifruitas.com

Copyright © 2024 Balai ni Fruitas
Web Design by WAZILE
  • Home
  • Our Company
    • What We Do
    • Who we are
    • Organizational Chart
    • Corporate Structure
    • Shareholdings’ Structure
  • Corporate Governance
    • Corporate Governance Documents
    • Board Committees
    • Corporate Social Responsibility
    • Company’s Policies
  • Company Disclosures
  • Investor Relations
    • Investor Relations Program
    • Share Information
    • Stock Information
    • Self-Side Coverage
    • Financial Calendar
    • Investment Highlights
    • FAQS
  • IPO Documents
  • Press Release
  • Latest News
  • Contact